Athersys Investor Relations Material
Latest events
Investor Update
Athersys
Q3 2023
16 Nov, 2023
Investor Presentation
24 Aug, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Athersys Inc
Access all reports
Athersys Inc is a biotechnology company focused on the research and development of regenerative medicine therapies. Its lead programs involve cell-based therapies for treating neurological conditions, inflammatory diseases, and cardiovascular indications. The company is headquartered in Cleveland, Ohio, and its shares are listed on the NASDAQ.
Latest articles
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
Ticker symbol
ATHX
Country
🇺🇸 United States